Stockreport

Annovis up 23% after webinar on neurodegeneration candidates [Seeking Alpha]

Annovis Bio, Inc.  (ANVS) 
PDF Thinly traded nano cap Annovis Bio (ANVS+22.6%Q&A sessionIts top three pipeline candidates all treat neurodegenerative disorders, principally Alzheimer's and Parkinson's [Read more]